These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1825515

  • 1. Controlled clinical study on the use of dichloromethylene diphosphonate in patients with breast carcinoma metastasizing to the skeleton.
    Martoni A, Guaraldi M, Camera P, Biagi R, Marri S, Beghé F, Pannuti F.
    Oncology; 1991; 48(2):97-101. PubMed ID: 1825515
    [Abstract] [Full Text] [Related]

  • 2. Treatment of bone metastases with dichloromethylene bisphosphonate.
    Francini G, Gonnelli S, Petrioli R, Conti F, Paffetti P, Gennari C.
    J Clin Oncol; 1992 Apr; 10(4):591-8. PubMed ID: 1532198
    [Abstract] [Full Text] [Related]

  • 3. Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton.
    Siris ES, Hyman GA, Canfield RE.
    Am J Med; 1983 Mar; 74(3):401-6. PubMed ID: 6219577
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of dichloromethylene diphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism.
    Elomaa I, Blomqvist C, Porkka L, Holmström T, Laine H.
    Cancer Treat Rep; 1984 Apr; 68(4):655-7. PubMed ID: 6231989
    [Abstract] [Full Text] [Related]

  • 5. Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.
    Elomaa I, Blomqvist C, Gröhn P, Porkka L, Kairento AL, Selander K, Lamberg-Allardt C, Holmström T.
    Lancet; 1983 Jan 22; 1(8317):146-9. PubMed ID: 6130197
    [Abstract] [Full Text] [Related]

  • 6. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
    Chapuy MC, Meunier PJ, Alexandre CM, Vignon EP.
    J Clin Invest; 1980 May 22; 65(5):1243-7. PubMed ID: 6444955
    [Abstract] [Full Text] [Related]

  • 7. Dichloromethylene diphosphonate action in hematologic and other malignancies.
    Canfield RE, Siris ES, Jacobs TP.
    Bone; 1987 May 22; 8 Suppl 1():S57-62. PubMed ID: 2961356
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)].
    Delmas P, Chapuy MC, Vignon E, Briançon D, Charhon S, Meunier PJ.
    Nouv Presse Med; 1982 Apr 24; 11(19):1471-4. PubMed ID: 6210878
    [Abstract] [Full Text] [Related]

  • 11. Clodronate for osteolytic metastases due to breast cancer.
    Elomaa I, Blomqvist C, Porkka L, Holmström T, Taube T, Lamberg-Allardt C, Borgström GH.
    Biomed Pharmacother; 1988 Apr 24; 42(2):111-6. PubMed ID: 2971403
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hypercalcemia in malignancies: treatment with dichloromethylene diphosphonate (Cl2MDP).
    Conte N, Di Virgilio R, Roiter I, Caberlotto L.
    Tumori; 1985 Feb 28; 71(1):51-4. PubMed ID: 3157251
    [Abstract] [Full Text] [Related]

  • 14. Effect of dichloromethylene diphosphonate (Cl2MDP) on immune function in breast cancer patients with bone metastases.
    Markkula R, Repo H, Leirisalo M, Blomqvist C, Elomaa I.
    Cancer Immunol Immunother; 1983 Feb 28; 15(2):159-61. PubMed ID: 6223692
    [Abstract] [Full Text] [Related]

  • 15. Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate.
    Shane E, Jacobs TP, Siris ES, Steinberg SF, Stoddart K, Canfield RE, Bilezikian JP.
    Am J Med; 1982 Jun 28; 72(6):939-44. PubMed ID: 6211978
    [Abstract] [Full Text] [Related]

  • 16. Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism.
    Shane E, Baquiran DC, Bilezikian JP.
    Ann Intern Med; 1981 Jul 28; 95(1):23-7. PubMed ID: 6264825
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma.
    Siris ES, Sherman WH, Baquiran DC, Schlatterer JP, Osserman EF, Canfield RE.
    N Engl J Med; 1980 Feb 07; 302(6):310-5. PubMed ID: 6444241
    [Abstract] [Full Text] [Related]

  • 19. Comparison of two parenteral diphosphonates in hypercalcemia of malignancy.
    Jung A.
    Am J Med; 1982 Feb 07; 72(2):221-6. PubMed ID: 6460442
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.